TheCardiovascular
loading…

P04.5 Newborn affected by maternal use of nutritional chemical substances

BackP04Newborn affected by noxious substances transmitted via placenta or breast milk9 →P04.0Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and deliveryP04.1Newborn affected by other maternal medication10 →P04.11Newborn affected by maternal antineoplastic chemotherapyP04.12Newborn affected by maternal cytotoxic drugsP04.13Newborn affected by maternal use of anticonvulsantsP04.14Newborn affected by maternal use of opiatesP04.15Newborn affected by maternal use of antidepressantsP04.16Newborn affected by maternal use of amphetaminesP04.17Newborn affected by maternal use of sedative-hypnoticsP04.18Newborn affected by other maternal medicationP04.19Newborn affected by maternal use of unspecified medicationP04.1ANewborn affected by maternal use of anxiolyticsP04.2Newborn affected by maternal use of tobaccoP04.3Newborn affected by maternal use of alcoholP04.4Newborn affected by maternal use of drugs of addiction4 →P04.40Newborn affected by maternal use of unspecified drugs of addictionP04.41Newborn affected by maternal use of cocaineP04.42Newborn affected by maternal use of hallucinogensP04.49Newborn affected by maternal use of other drugs of addictionP04.5Newborn affected by maternal use of nutritional chemical substancesP04.6Newborn affected by maternal exposure to environmental chemical substancesP04.8Newborn affected by other maternal noxious substances2 →P04.81Newborn affected by maternal use of cannabisP04.89Newborn affected by other maternal noxious substancesP04.9Newborn affected by maternal noxious substance, unspecified
CategoryCODABLE
P04.5
Newborn affected by maternal use of nutritional chemical substances
Chapter
XVI · Certain conditions originating in the perinatal period
Section
P00-P04
Valid from
Source

CMS ICD-10-CM Tabular List, edition FY2026.

Search articles →